• Laporte M et al. (2025). A coronavirus assembly inhibitor that targets the viral membrane protein. Nature. 640(8058): 514–523. doi: 10.1038/s41586-025-08773-x
• Feracci et al. (2023). AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5. Antiviral Res. 212: 105574. doi: 10.1016/j.antiviral.2023.105574
• Shannon et al. (2022). A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase. Nat Commun. 13(1): 621. doi: 10.1038/s41467-022-28113-1
• Lo HS et al. (2021). Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir. ACS Cent Sci. 7(5): 792–802. doi: 10.1021/acscentsci.0c01186
• Eydoux et al. (2021). A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex. J Virol Methods. 288: 114013. doi: 10.1016/j.jviromet.2020.114013
• Shannon et al. (2020). Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Res. 178: 104793. doi: 10.1016/j.antiviral.2020.104793